InsidersTradesSigma
Follow the 옵투스제약 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 옵투스제약 has recorded 12 reports. Market capitalisation: €89.4bn. The latest transaction was reported on 12 June 2026 (Purchase). Among the most active insiders: 옵투스제약. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
12 of 12 declarations
Optus Pharmaceutical 是一家在 XKRX 市场上市的健康和制药公司。它专注于药品开发和分销。